DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/ppn434/raptor) has announced the addition of Global Markets Direct's new company profile "Raptor Pharmaceuticals Corp. - Product Pipeline Review - 2012" to their offering.
This report provides data on the Raptor Pharmaceuticals Corp.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
- Raptor Pharmaceuticals Corp. - Brief Raptor Pharmaceuticals Corp. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Raptor Pharmaceuticals Corp. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Raptor Pharmaceuticals Corp. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Raptor Pharmaceuticals Corp.'s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.
Reasons to Buy:
- Evaluate Raptor Pharmaceuticals Corp.'s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Raptor Pharmaceuticals Corp. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Raptor Pharmaceuticals Corp.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Raptor Pharmaceuticals Corp..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Raptor Pharmaceuticals Corp. and identify potential opportunities in those areas.
For more information visit http://www.researchandmarkets.com/research/ppn434/raptor
Source: Global Markets Direct
Source: Research and Markets